Enter asthma patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts
From EULAR 2020, new data from RABBIT trial assessing risk of herpes zoster infection among RA patients by class of DMARD, as reported by CCO
New from EULAR 2020: risk of JAKi, IL-6i, abatacept vs TNFi discontinuation among patients with rheumatoid arthritis, as reported by Clinical Care Options (CCO)
From EULAR 2020, new safety analysis of risk for thromboembolic events with tofacitinib and baricitinib in RA, reported by Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.